Prevalence and correlates of elevated body mass index among HIV-positive and HIV-negative women in the women's interagency HIV study

Basmattee Boodram, Michael W. Plankey, Christopher Cox, Phyllis C. Tien, Mardge H. Cohen, Kathryn Anastos, Roksana Karim, Charles Hyman, Ronald C. Hershow

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Since the introduction of highly active antiretroviral therapy (HAART) and the subsequent increased life expectancy in HIV-infected persons, non-HIV-related diseases have become an important cause of morbidity and mortality. This cross-sectional study reports the prevalence of overweight and obesity, and sociodemographic, psychological, and substance use-related risk factors for elevated body mass index (BMI) among 2157 HIV-seropositive (HIV+) in comparison to 730 HIV-seronegative (HIV-) participants in the Women's Interagency HIV Study (WIHS). Separate univariable and multivariate linear regression analyses were completed for HIV+ and HIV- women. Our study revealed a similar proportion of obesity (body mass index [BMI] ≥30) among HIV+ (33%) and HIV- women (29%) (p = 0.12), as well as comparable median BMI (HIV+: 26.1 versus HIV-: 26.7, p = 0.16). HIV+ compared to HIV- women, respectively, were significantly (p < 0.01) older (median = 35.6 versus. 32.5), but similar (p = 0.97) by race/ethnicity (57% African American, 28% Hispanic, and 15% white for both). In multivariate models for both HIV+ and HIV- women, African American race/ethnicity was significantly (p < 0.05) associated with higher BMI, while higher quality of life score and illicit hard drug use were associated with lower BMI. Additionally, smoking, alcohol use, markers of advanced HIV infection (AIDS diagnosis, elevated HIV viral load, low CD4 count), and a history of antiretroviral therapy use (ART) were also associated with lower BMI among HIV+ women. In conclusion, risk factors for elevated BMI were similar for HIV+ and HIV- women in the WIHS. For HIV+ women, all markers of advanced HIV infection and ART use were additionally associated with lower BMI.

Original languageEnglish (US)
Pages (from-to)1009-1016
Number of pages8
JournalAIDS Patient Care and STDs
Volume23
Issue number12
DOIs
StatePublished - Dec 1 2009

Fingerprint

Body Mass Index
HIV
African Americans
HIV Infections
Obesity
Highly Active Antiretroviral Therapy
Street Drugs
CD4 Lymphocyte Count
Life Expectancy
Viral Load
Hispanic Americans

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Cite this

Prevalence and correlates of elevated body mass index among HIV-positive and HIV-negative women in the women's interagency HIV study. / Boodram, Basmattee; Plankey, Michael W.; Cox, Christopher; Tien, Phyllis C.; Cohen, Mardge H.; Anastos, Kathryn; Karim, Roksana; Hyman, Charles; Hershow, Ronald C.

In: AIDS Patient Care and STDs, Vol. 23, No. 12, 01.12.2009, p. 1009-1016.

Research output: Contribution to journalArticle

Boodram, Basmattee ; Plankey, Michael W. ; Cox, Christopher ; Tien, Phyllis C. ; Cohen, Mardge H. ; Anastos, Kathryn ; Karim, Roksana ; Hyman, Charles ; Hershow, Ronald C. / Prevalence and correlates of elevated body mass index among HIV-positive and HIV-negative women in the women's interagency HIV study. In: AIDS Patient Care and STDs. 2009 ; Vol. 23, No. 12. pp. 1009-1016.
@article{838bd28c2c3d4b668ef281414b6997b2,
title = "Prevalence and correlates of elevated body mass index among HIV-positive and HIV-negative women in the women's interagency HIV study",
abstract = "Since the introduction of highly active antiretroviral therapy (HAART) and the subsequent increased life expectancy in HIV-infected persons, non-HIV-related diseases have become an important cause of morbidity and mortality. This cross-sectional study reports the prevalence of overweight and obesity, and sociodemographic, psychological, and substance use-related risk factors for elevated body mass index (BMI) among 2157 HIV-seropositive (HIV+) in comparison to 730 HIV-seronegative (HIV-) participants in the Women's Interagency HIV Study (WIHS). Separate univariable and multivariate linear regression analyses were completed for HIV+ and HIV- women. Our study revealed a similar proportion of obesity (body mass index [BMI] ≥30) among HIV+ (33{\%}) and HIV- women (29{\%}) (p = 0.12), as well as comparable median BMI (HIV+: 26.1 versus HIV-: 26.7, p = 0.16). HIV+ compared to HIV- women, respectively, were significantly (p < 0.01) older (median = 35.6 versus. 32.5), but similar (p = 0.97) by race/ethnicity (57{\%} African American, 28{\%} Hispanic, and 15{\%} white for both). In multivariate models for both HIV+ and HIV- women, African American race/ethnicity was significantly (p < 0.05) associated with higher BMI, while higher quality of life score and illicit hard drug use were associated with lower BMI. Additionally, smoking, alcohol use, markers of advanced HIV infection (AIDS diagnosis, elevated HIV viral load, low CD4 count), and a history of antiretroviral therapy use (ART) were also associated with lower BMI among HIV+ women. In conclusion, risk factors for elevated BMI were similar for HIV+ and HIV- women in the WIHS. For HIV+ women, all markers of advanced HIV infection and ART use were additionally associated with lower BMI.",
author = "Basmattee Boodram and Plankey, {Michael W.} and Christopher Cox and Tien, {Phyllis C.} and Cohen, {Mardge H.} and Kathryn Anastos and Roksana Karim and Charles Hyman and Hershow, {Ronald C.}",
year = "2009",
month = "12",
day = "1",
doi = "10.1089/apc.2009.0175",
language = "English (US)",
volume = "23",
pages = "1009--1016",
journal = "AIDS Patient Care and STDs",
issn = "1087-2914",
publisher = "Mary Ann Liebert Inc.",
number = "12",

}

TY - JOUR

T1 - Prevalence and correlates of elevated body mass index among HIV-positive and HIV-negative women in the women's interagency HIV study

AU - Boodram, Basmattee

AU - Plankey, Michael W.

AU - Cox, Christopher

AU - Tien, Phyllis C.

AU - Cohen, Mardge H.

AU - Anastos, Kathryn

AU - Karim, Roksana

AU - Hyman, Charles

AU - Hershow, Ronald C.

PY - 2009/12/1

Y1 - 2009/12/1

N2 - Since the introduction of highly active antiretroviral therapy (HAART) and the subsequent increased life expectancy in HIV-infected persons, non-HIV-related diseases have become an important cause of morbidity and mortality. This cross-sectional study reports the prevalence of overweight and obesity, and sociodemographic, psychological, and substance use-related risk factors for elevated body mass index (BMI) among 2157 HIV-seropositive (HIV+) in comparison to 730 HIV-seronegative (HIV-) participants in the Women's Interagency HIV Study (WIHS). Separate univariable and multivariate linear regression analyses were completed for HIV+ and HIV- women. Our study revealed a similar proportion of obesity (body mass index [BMI] ≥30) among HIV+ (33%) and HIV- women (29%) (p = 0.12), as well as comparable median BMI (HIV+: 26.1 versus HIV-: 26.7, p = 0.16). HIV+ compared to HIV- women, respectively, were significantly (p < 0.01) older (median = 35.6 versus. 32.5), but similar (p = 0.97) by race/ethnicity (57% African American, 28% Hispanic, and 15% white for both). In multivariate models for both HIV+ and HIV- women, African American race/ethnicity was significantly (p < 0.05) associated with higher BMI, while higher quality of life score and illicit hard drug use were associated with lower BMI. Additionally, smoking, alcohol use, markers of advanced HIV infection (AIDS diagnosis, elevated HIV viral load, low CD4 count), and a history of antiretroviral therapy use (ART) were also associated with lower BMI among HIV+ women. In conclusion, risk factors for elevated BMI were similar for HIV+ and HIV- women in the WIHS. For HIV+ women, all markers of advanced HIV infection and ART use were additionally associated with lower BMI.

AB - Since the introduction of highly active antiretroviral therapy (HAART) and the subsequent increased life expectancy in HIV-infected persons, non-HIV-related diseases have become an important cause of morbidity and mortality. This cross-sectional study reports the prevalence of overweight and obesity, and sociodemographic, psychological, and substance use-related risk factors for elevated body mass index (BMI) among 2157 HIV-seropositive (HIV+) in comparison to 730 HIV-seronegative (HIV-) participants in the Women's Interagency HIV Study (WIHS). Separate univariable and multivariate linear regression analyses were completed for HIV+ and HIV- women. Our study revealed a similar proportion of obesity (body mass index [BMI] ≥30) among HIV+ (33%) and HIV- women (29%) (p = 0.12), as well as comparable median BMI (HIV+: 26.1 versus HIV-: 26.7, p = 0.16). HIV+ compared to HIV- women, respectively, were significantly (p < 0.01) older (median = 35.6 versus. 32.5), but similar (p = 0.97) by race/ethnicity (57% African American, 28% Hispanic, and 15% white for both). In multivariate models for both HIV+ and HIV- women, African American race/ethnicity was significantly (p < 0.05) associated with higher BMI, while higher quality of life score and illicit hard drug use were associated with lower BMI. Additionally, smoking, alcohol use, markers of advanced HIV infection (AIDS diagnosis, elevated HIV viral load, low CD4 count), and a history of antiretroviral therapy use (ART) were also associated with lower BMI among HIV+ women. In conclusion, risk factors for elevated BMI were similar for HIV+ and HIV- women in the WIHS. For HIV+ women, all markers of advanced HIV infection and ART use were additionally associated with lower BMI.

UR - http://www.scopus.com/inward/record.url?scp=77149168135&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77149168135&partnerID=8YFLogxK

U2 - 10.1089/apc.2009.0175

DO - 10.1089/apc.2009.0175

M3 - Article

C2 - 19909168

AN - SCOPUS:77149168135

VL - 23

SP - 1009

EP - 1016

JO - AIDS Patient Care and STDs

JF - AIDS Patient Care and STDs

SN - 1087-2914

IS - 12

ER -